SATOLLI, Maria Antonietta
SATOLLI, Maria Antonietta
ONCOLOGIA
[New therapeutic options in the treatment of hepatocellular carcinoma]
2001-01-01 Martinotti, R; Evangelista, W; Goss, M; Angelini, F; Satolli, M A
[Solitary fibrous tumor of the pleura. Clinical case]
1996-01-01 TROMBETTA F ;SANDRUCCI S ;MOSCATO R ;SATOLLI MA
[Two cases of melanoma metastasis. Description and review of the literature]
1996-01-01 Zanon, C; Satolli, M A; Alabiso, O; Grassi, L; Miraglia, S
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy
2021-01-01 Filippi R.; Montagnani F.; Lombardi P.; Fornaro L.; Aprile G.; Casadei-Gardini A.; Faloppi L.; Palloni A.; Satolli M.A.; Scartozzi M.; Citarella F.; Lutrino S.E.; Vivaldi C.; Silvestris N.; Rovesti G.; Rimini M.; Aglietta M.; Brandi G.; Leone F.
Advanced non-small cell lung cancer in elderly patients: A review
2015-01-01 Buffoni, Lucio; Consito, Lorena; Filippi, Andrea Riccardo; Ruffini, Enrico; Solidoro, Paolo; Bironzo, Paolo; Satolli, Maria Antonietta; Schena, Marina; Ciuffreda, Libero
Antibody and T cell response profiling in pancreatic cancer patients before and after chemotherapy identify tumor associated antigens suitable for immunotherapy
2018-01-01 Sara Bulfamante, Giorgia Mandili, Moitza Principe, Daniele Giordano, Emanuela Mazza, Claudia Curcio, Laura Follia, Giulio Ferrero, Andrea Evangelista, Maria Antonietta Satolli, Paola Cappello, Francesco Novelli
Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer.
2012-01-01 S. Asioli; F. Maletta; L. Verdun di Cantogno; M. A. Satolli; M. Schena; C. Pecchioni; C. Botta; L. Chiusa; L. Molinaro; L. Conti; G. Viale; G. Ingravallo; E. Maiorano; A. Sapino
Benign metastatic meningioma: clinico-pathological analysis of one case metastasising to the lung and overview on the concepts of either primitive or metastatic meningiomas of the lung
2007-01-01 S. ASIOLI; R. SENETTA; E. MALDI; E. D'AMBROSIO; M.A. SATOLLI; G. BUSSOLATI; P. CASSONI
Bone metastases in gastric cancer follow a RANKL-independent mechanism.
2013-01-01 D'Amico L; Satolli MA; Mecca C; Castiglione A; Ceccarelli M; D'Amelio P; Garino M; DeGiuli M; Sandrucci S; Ferracini R; Roato I
Chimeric Rat/Human HER2 Efficiently Circumvents HER2 Tolerance in Cancer Patients.
2014-01-01 Occhipinti S; Sponton L; Rolla S; Caorsi C; Novarino A; Donadio M; Bustreo S; Satolli MA; Pecchioni C; Marchini C; Amici A; Cavallo F; Cappello P; Pierobon D; Novelli F; Giovarelli M.
Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients.
2011-01-01 Santini D; Vincenzi B; Adamo V; Addeo R; Fusco V; Russo A; Montemurro F; Roato I; Redana S; Lanzetta G; Satolli MA; Berruti A; Leoni V; Galluzzo S; Antimi M; Ferraro G; Rossi M; Del Prete S; Valerio MR; Marra M; Caraglia M; Tonini G.
Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival
2023-01-01 Curcio C.; Rosso T.; Brugiapaglia S.; Guadagnin G.; Giordano D.; Castellino B.; Satolli M.A.; Spadi R.; Campra D.; Moro F.; Papotti M.G.; Bertero L.; Cassoni P.; De Angelis C.; Langella S.; Ferrero A.; Armentano S.; Bellotti G.; Fenocchio E.; Nuzzo A.; Ciccone G.; Novelli F.
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis
2022-01-01 Filippi R.; Leone F.; Fornaro L.; Aprile G.; Casadei-Gardini A.; Silvestris N.; Palloni A.; Satolli M.A.; Scartozzi M.; Russano M.; Lutrino S.E.; Lombardi P.; Frega G.; Garattini S.K.; Vivaldi C.; Spadi R.; Giulia O.; Fenocchio E.; Brunetti O.; Aglietta M.; Brandi G.
Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinoma
2012-01-01 Vizio B.; Mauri FA; Prati A; Trivedi P; Giacobino A; Novarino A; Satolli MA; Ciuffreda L; Camandona M; Gasparri G; Bellone G.
Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians
2016-01-01 Spadi R.; Brusa F.; Ponzetti A.; Chiappino I.; Birocco N.; Ciuffreda L.; Satolli M.A.
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study
2024-01-01 Margherita Rimini, Gianluca Masi, Sara Lonardi, Federico Nichetti, Tiziana Pressiani, Daniele Lavacchi, Lucchetti Jessica, Guido Giordano, Mario Scartozzi, Emiliano Tamburini, Alessandro Pastorino, Ilario Giovanni Rapposelli, Bruno Daniele, Erika Martinelli, Ingrid Garajova, Giuseppe Aprile, Marta Schirripa, Vincenzo Formica, Francesca Salani, Costanza Winchler, Francesca Bergamo, Rita Balsano, Eleonora Gusmaroli, Angotti Lorenzo, Matteo Landriscina, Andrea Pretta, Ilaria Toma, Chiara Pirrone, Anna Diana, Francesco Leone, Oronzo Brunetti, Giovanni Brandi, Silvio Ken Garattini, Maria Antonietta Satolli, Federico Rossari, Lorenzo Fornaro, Monica Niger, Valentina Zanuso, Antonio De Rosa, Francesca Ratti, Luca Aldrighetti, Filippo De Braud, Silvia Foti, Mario Domenico Rizzato, Caterina Vivaldi, Cascinu Stefano, Lorenza Rimassa , Lorenzo Antonuzzo, Andrea Casadei-Gardini.
Evaluating larotrectinib for the treatment of advanced solid tumors harboring an NTRK gene fusion
2021-01-01 Filippi R.; Depetris I.; Satolli M.A.
FOLFOX-4 regimen or single-agent gemcitabine as first-line chemotherapy in advanced biliary tract cancer.
2013-01-01 Novarino AM; Satolli MA; Chiappino I; Giacobino A; Napoletano R; Ceccarelli M; Ciccone G; Schena M; Bertetto O; Ciuffreda L.
Gastric Cancer: The Times they are a-changin’
2015-01-01 Satolli M.A.; Buffoni L.; Spadi R.; Roato I.
IL17A CRITICALLY SHAPES THE TRANSCRIPTIONAL PROGRAM OF FIBROBLASTS IN PANCREATIC CANCER AND SWITCHES ON THEIR PRO-TUMORIGENIC FUNCTIONS
2021-01-01 G Mucciolo , C Curcio, C Roux , W Li , M Capello, R Curto, R Chiarle, D Giordano, MA Satolli, R Lawlor, A Scarpa, P Lukac, D Stakheev, P Provero, L Vannucci, TW. Mak, F Novelli, P Cappello
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| [New therapeutic options in the treatment of hepatocellular carcinoma] | 2001 | Martinotti, R; Evangelista, W; Goss, M; Angelini, F; Satolli, M A | |
| [Solitary fibrous tumor of the pleura. Clinical case] | 1996 | TROMBETTA F ;SANDRUCCI S ;MOSCATO R ;SATOLLI MA | |
| [Two cases of melanoma metastasis. Description and review of the literature] | 1996 | Zanon, C; Satolli, M A; Alabiso, O; Grassi, L; Miraglia, S | |
| A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy | 2021 | Filippi R.; Montagnani F.; Lombardi P.; Fornaro L.; Aprile G.; Casadei-Gardini A.; Faloppi L.; Palloni A.; Satolli M.A.; Scartozzi M.; Citarella F.; Lutrino S.E.; Vivaldi C.; Silvestris N.; Rovesti G.; Rimini M.; Aglietta M.; Brandi G.; Leone F. | |
| Advanced non-small cell lung cancer in elderly patients: A review | 2015 | Buffoni, Lucio; Consito, Lorena; Filippi, Andrea Riccardo; Ruffini, Enrico; Solidoro, Paolo; Bironzo, Paolo; Satolli, Maria Antonietta; Schena, Marina; Ciuffreda, Libero | |
| Antibody and T cell response profiling in pancreatic cancer patients before and after chemotherapy identify tumor associated antigens suitable for immunotherapy | 2018 | Sara Bulfamante, Giorgia Mandili, Moitza Principe, Daniele Giordano, Emanuela Mazza, Claudia Curcio, Laura Follia, Giulio Ferrero, Andrea Evangelista, Maria Antonietta Satolli, Paola Cappello, Francesco Novelli | |
| Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer. | 2012 | S. Asioli; F. Maletta; L. Verdun di Cantogno; M. A. Satolli; M. Schena; C. Pecchioni; C. Botta; L. Chiusa; L. Molinaro; L. Conti; G. Viale; G. Ingravallo; E. Maiorano; A. Sapino | |
| Benign metastatic meningioma: clinico-pathological analysis of one case metastasising to the lung and overview on the concepts of either primitive or metastatic meningiomas of the lung | 2007 | S. ASIOLI; R. SENETTA; E. MALDI; E. D'AMBROSIO; M.A. SATOLLI; G. BUSSOLATI; P. CASSONI | |
| Bone metastases in gastric cancer follow a RANKL-independent mechanism. | 2013 | D'Amico L; Satolli MA; Mecca C; Castiglione A; Ceccarelli M; D'Amelio P; Garino M; DeGiuli M; Sandrucci S; Ferracini R; Roato I | |
| Chimeric Rat/Human HER2 Efficiently Circumvents HER2 Tolerance in Cancer Patients. | 2014 | Occhipinti S; Sponton L; Rolla S; Caorsi C; Novarino A; Donadio M; Bustreo S; Satolli MA; Pecchioni C; Marchini C; Amici A; Cavallo F; Cappello P; Pierobon D; Novelli F; Giovarelli M. | |
| Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients. | 2011 | Santini D; Vincenzi B; Adamo V; Addeo R; Fusco V; Russo A; Montemurro F; Roato I; Redana S; Lanzetta G; Satolli MA; Berruti A; Leoni V; Galluzzo S; Antimi M; Ferraro G; Rossi M; Del Prete S; Valerio MR; Marra M; Caraglia M; Tonini G. | |
| Circulating autoantibodies to alpha-enolase (ENO1) and far upstream element-binding protein 1 (FUBP1) are negative prognostic factors for pancreatic cancer patient survival | 2023 | Curcio C.; Rosso T.; Brugiapaglia S.; Guadagnin G.; Giordano D.; Castellino B.; Satolli M.A.; Spadi R.; Campra D.; Moro F.; Papotti M.G.; Bertero L.; Cassoni P.; De Angelis C.; Langella S.; Ferrero A.; Armentano S.; Bellotti G.; Fenocchio E.; Nuzzo A.; Ciccone G.; Novelli F. | |
| Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis | 2022 | Filippi R.; Leone F.; Fornaro L.; Aprile G.; Casadei-Gardini A.; Silvestris N.; Palloni A.; Satolli M.A.; Scartozzi M.; Russano M.; Lutrino S.E.; Lombardi P.; Frega G.; Garattini S.K.; Vivaldi C.; Spadi R.; Giulia O.; Fenocchio E.; Brunetti O.; Aglietta M.; Brandi G. | |
| Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinoma | 2012 | Vizio B.; Mauri FA; Prati A; Trivedi P; Giacobino A; Novarino A; Satolli MA; Ciuffreda L; Camandona M; Gasparri G; Bellone G. | |
| Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians | 2016 | Spadi R.; Brusa F.; Ponzetti A.; Chiappino I.; Birocco N.; Ciuffreda L.; Satolli M.A. | |
| Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study | 2024 | Margherita Rimini, Gianluca Masi, Sara Lonardi, Federico Nichetti, Tiziana Pressiani, Daniele Lavacchi, Lucchetti Jessica, Guido Giordano, Mario Scartozzi, Emiliano Tamburini, Alessandro Pastorino, Ilario Giovanni Rapposelli, Bruno Daniele, Erika Martinelli, Ingrid Garajova, Giuseppe Aprile, Marta Schirripa, Vincenzo Formica, Francesca Salani, Costanza Winchler, Francesca Bergamo, Rita Balsano, Eleonora Gusmaroli, Angotti Lorenzo, Matteo Landriscina, Andrea Pretta, Ilaria Toma, Chiara Pirrone, Anna Diana, Francesco Leone, Oronzo Brunetti, Giovanni Brandi, Silvio Ken Garattini, Maria Antonietta Satolli, Federico Rossari, Lorenzo Fornaro, Monica Niger, Valentina Zanuso, Antonio De Rosa, Francesca Ratti, Luca Aldrighetti, Filippo De Braud, Silvia Foti, Mario Domenico Rizzato, Caterina Vivaldi, Cascinu Stefano, Lorenza Rimassa , Lorenzo Antonuzzo, Andrea Casadei-Gardini. | |
| Evaluating larotrectinib for the treatment of advanced solid tumors harboring an NTRK gene fusion | 2021 | Filippi R.; Depetris I.; Satolli M.A. | |
| FOLFOX-4 regimen or single-agent gemcitabine as first-line chemotherapy in advanced biliary tract cancer. | 2013 | Novarino AM; Satolli MA; Chiappino I; Giacobino A; Napoletano R; Ceccarelli M; Ciccone G; Schena M; Bertetto O; Ciuffreda L. | |
| Gastric Cancer: The Times they are a-changin’ | 2015 | Satolli M.A.; Buffoni L.; Spadi R.; Roato I. | |
| IL17A CRITICALLY SHAPES THE TRANSCRIPTIONAL PROGRAM OF FIBROBLASTS IN PANCREATIC CANCER AND SWITCHES ON THEIR PRO-TUMORIGENIC FUNCTIONS | 2021 | G Mucciolo , C Curcio, C Roux , W Li , M Capello, R Curto, R Chiarle, D Giordano, MA Satolli, R Lawlor, A Scarpa, P Lukac, D Stakheev, P Provero, L Vannucci, TW. Mak, F Novelli, P Cappello |